A Roma founder BIN1 mutation causes a novel phenotype of centronuclear myopathy with rigid spine
Authors:
- Macarena Cabrera-SerranoMCMacarena Cabrera-Serrano
- Fabiola MavillardFMFabiola Mavillard
- Valerie BiancalanaVBValerie Biancalana
- Eloy RivasEREloy Rivas
- Bharti MorarBMBharti Morar
- Aurelio Hernández-LaínAHAurelio Hernández-Laín
- Montse OliveMOMontse Olive
- Nuria MuelasNMNuria Muelas
- Eduardo KhanEKEduardo Khan
- Alejandra CarvajalACAlejandra Carvajal
- Pablo QuirogaPQPablo Quiroga
- Jordi Diaz-ManeraJDJordi Diaz-Manera
- 24 July 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 91 (4) , e339-e348
Abstract
Objective To describe a large series of BIN1 patients, in which a novel founder mutation in the Roma population of southern Spain has been identified. Methods Patients diagnosed with centronuclear myopathy (CNM) at 5 major reference centers for neuromuscular disease in Spain (n = 53) were screened for BIN1 mutations. Clinical, histologic, radiologic, and genetic features were analyzed. Results Eighteen patients from 13 families carried the p.Arg234Cys variant; 16 of them were homozygous for it and 2 had compound heterozygous p.Arg234Cys/p.Arg145Cys mutations. Both BIN1 variants have only been identified in Roma, causing 100% of CNM in this ethnic group in our cohort. The haplotype analysis confirmed all families are related. In addition to clinical features typical of CNM, such as proximal limb weakness and ophthalmoplegia, most patients in our cohort presented with prominent axial weakness, often associated with rigid spine. Severe fat replacement of paravertebral muscles was demonstrated by muscle imaging. This phenotype seems to be specific to the p.Arg234Cys mutation, not reported in other BIN1 mutations. Extreme clinical variability was observed in the 2 compound heterozygous patients for the p.Arg234Cys/p.Arg145Cys mutations, from a congenital onset with catastrophic outcome to a late-onset disease. Screening of European Roma controls (n = 758) for the p.Arg234Cys variant identified a carrier frequency of 3.5% among the Spanish Roma. Conclusion We have identified a BIN1 founder Roma mutation associated with a highly specific phenotype, which is, from the present cohort, the main cause of CNM in Spain.Keywords
This publication has 22 references indexed in Scilit:
- Amphiphysin 2 Orchestrates Nucleus Positioning and Shape by Linking the Nuclear Envelope to the Actin and Microtubule CytoskeletonDevelopmental Cell, 2015
- Centronuclear myopathies: genotype–phenotype correlation and frequency of defined genetic forms in an Italian cohortJournal of Neurology, 2015
- Mutations in BIN1 Associated with Centronuclear Myopathy Disrupt Membrane Remodeling by Affecting Protein Density and OligomerizationPLOS ONE, 2014
- Amphiphysin 2 (BIN1) in physiology and diseasesJournal of Molecular Medicine, 2014
- Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear MyopathyPLOS Genetics, 2013
- Centronuclear MyopathiesSeminars in Pediatric Neurology, 2011
- Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutationOrphanet Journal of Rare Diseases, 2010
- PHENOTYPE OF A PATIENT WITH RECESSIVE CENTRONUCLEAR MYOPATHY AND A NOVEL BIN1 MUTATIONNeurology, 2010
- The BAR Domain Superfamily: Membrane-Molding MacromoleculesCell, 2009
- Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathyNature Genetics, 2007